CORRECTION
Correction: Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression Howard R. Weeks, III, Scott C. Tadler, Kelly W. Smith, Eli Iacob, Mikala Saccoman, Andrea T. White, Joshua D. Landvatter, Gordon J. Chelune, Yana Suchy, Elaine Clark, Michael K. Cahalan, Lowry Bushnell, Derek Sakata, Alan R. Light, Kathleen C. Light
The following information is missing from the Competing Interests section: At the time of the study, author DS had an equity interest in Anecare, a commercial company, which holds the license to the ANEclear device that was used in the study. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
Reference 1.
Weeks HR III, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, et al. (2013) Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression. PLoS ONE 8(7): e69809. https://doi.org/10.1371/journal.pone.0069809 PMID: 23922809
a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
OPEN ACCESS Citation: Weeks HR, III, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, et al. (2017) Correction: Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression. PLoS ONE 12(4): e0175668. https:// doi.org/10.1371/journal.pone.0175668 Published: April 6, 2017 Copyright: © 2017 Weeks et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS ONE | https://doi.org/10.1371/journal.pone.0175668 April 6, 2017
1/1
Correction: Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression Howard R. Weeks, III, Scott C. Tadler, Kelly W. Smith, Eli Iacob, Mikala Saccoman, Andrea T. White, Joshua D. Landvatter, Gordon J. Chelune, Yana Suchy, Elaine Clark, Michael K. Cahalan, Lowry Bushnell, Derek Sakata, Alan R. Light, Kathleen C. Light
The following information is missing from the Competing Interests section: At the time of the study, author DS had an equity interest in Anecare, a commercial company, which holds the license to the ANEclear device that was used in the study. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
Reference 1.
Weeks HR III, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, et al. (2013) Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression. PLoS ONE 8(7): e69809. https://doi.org/10.1371/journal.pone.0069809 PMID: 23922809
a1111111111 a1111111111 a1111111111 a1111111111 a1111111111
OPEN ACCESS Citation: Weeks HR, III, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, et al. (2017) Correction: Antidepressant and Neurocognitive Effects of Isoflurane Anesthesia versus Electroconvulsive Therapy in Refractory Depression. PLoS ONE 12(4): e0175668. https:// doi.org/10.1371/journal.pone.0175668 Published: April 6, 2017 Copyright: © 2017 Weeks et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLOS ONE | https://doi.org/10.1371/journal.pone.0175668 April 6, 2017
1/1
